🔎 Trials Near Me

Hjem › Melanom › District of Columbia › Washington

Kliniske studier for Melanom i Washington, DC

17 studier for Melanom søker deltakere på steder i og rundt Washington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • National Cancer Institute (NCI), Bethesda · 7 mi unna
  • National Institutes of Health Clinical Center, Bethesda · 7 mi unna
4 Weeks – 99 Years · Alle kjønn · Oppdatert 2. okt. 2026 · NCT00040352

Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma

RekruttererFase 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Alder 18 til 120 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05155033

Evaluation for NCI Surgery Branch Clinical Research Protocols

RekruttererObservasjonsstudie
  • National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT00001823

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi unna
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

RekruttererFase 3
  • National Cancer Institute, Bethesda · 7 mi unna
Alder 18 til 70 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT05727904

A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

RekruttererFase 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Alder 18 til 120 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06066138

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

RekruttererFase 1/2
  • Sibley Memorial Hospital, Washington D.C.
Alder 18 og eldre · Alle kjønn · Oppdatert 31. aug. 2026 · NCT05896839

Project: Every Child for Younger Patients With Cancer

RekruttererObservasjonsstudie
  • MedStar Georgetown University Hospital, Washington D.C.
  • Children's National Medical Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi unna
Opp til 25 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT02402244

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RekruttererFase 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04851119

A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab

RekruttererFase 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Alder 18 til 72 · Alle kjønn · Oppdatert 20. aug. 2026 · NCT02621021

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

RekruttererFase 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Alder 18 til 72 · Alle kjønn · Oppdatert 13. aug. 2026 · NCT02830724

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

RekruttererFase 1/2
  • National Institutes of Health, Bethesda · 7 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT05592626

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

RekruttererFase 2
  • USA11-0, Bethesda · 7 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 22. mai 2026 · NCT06953089

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Cancer Support Community Research & Training Institute, Washington D.C.
Alder 18 og eldre · Alle kjønn · Oppdatert 23. apr. 2026 · NCT02333604

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

RekruttererFase 2/3
  • Georgetown University Medical Center, Washington D.C.
Alle aldre · Alle kjønn · Oppdatert 2. apr. 2026 · NCT06581406

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RekruttererObservasjonsstudie
  • Massive Bio SYNERGY-AI site, Silver Spring · 7 mi unna
  • Massive Bio SYNERGY-AI site, Bethesda · 7 mi unna
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Rekrutterer
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
Alder 18 og eldre · Alle kjønn · Oppdatert 27. nov. 2024 · NCT03860883

Melanom-studier i andre byer

Andre studier i Washington

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.